Richard M Stone (Richard Stone)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 53

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Newly Diagnosed

Ulcerative Colitis

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

American journal of hematology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Shai Shimony, Jan Philipp Bewersdorf, Rory Michael Shallis, Yiwen Liu, Eva J Schaefer, Amer M Zeidan, Aaron D Goldberg, Eytan M Stein, Guido Marcucci, R Coleman Lindsley, Evan C Chen, Jorge Ramos Perez, Anthony Stein, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Brian Ball, Maximilian Stahl
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML. Leukemia 38 (4) (2024)
Shai Shimony, Jan Philipp Bewersdorf, Rory Michael Shallis, Yiwen Liu, Eva J Schaefer, Amer M Zeidan, Aaron D Goldberg, Eytan M Stein, Guido Marcucci, R Coleman Lindsley, Evan C Chen, Jorge Ramos Perez, Anthony Stein, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Brian Ball, Maximilian Stahl
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML. Leukemia (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia 38 (9) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Shai Shimony, Jan Philipp Bewersdorf, Rory Michael Shallis, Yiwen Liu, Eva J Schaefer, Amer M Zeidan, Aaron D Goldberg, Eytan M Stein, Guido Marcucci, R Coleman Lindsley, Evan C Chen, Jorge Ramos Perez, Anthony Stein, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Brian Ball, Maximilian Stahl
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML. Leukemia 38 (4) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Shai Shimony, Jan Philipp Bewersdorf, Rory Michael Shallis, Yiwen Liu, Eva J Schaefer, Amer M Zeidan, Aaron D Goldberg, Eytan M Stein, Guido Marcucci, R Coleman Lindsley, Evan C Chen, Jorge Ramos Perez, Anthony Stein, Daniel J DeAngelo, Donna S Neuberg, Richard M Stone, Brian Ball, Maximilian Stahl
Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML. Leukemia 38 (4) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia (2024)
Ghayas C Issa, Ibrahim Aldoss, Michael J Thirman, John F Dipersio, Martha Arellano, James S Blachly, Gabriel N Mannis, Alexander E Perl, David S Dickens, Christine M McMahon, Jennifer Dunlap, Christian Michel Zwaan, Carolyn S Grove, Richard M Stone, Paul J Shami, Ioannis Mantzaris, Matthew Greenwood, Neerav N Shukla, Branko Cuglievan, Tibor Kovacsovics, Yu Gu, Rebecca G Bagley, Kate Madigan, Yakov Chudnovsky, Huy Van Nguyen, Nicole McNeer, Eytan M Stein
Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia 38 (9) (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, Ing Soo Tiong, Chong Chyn Chua, Tse-Chieh Teh, Chun Yew Fong, Stephen B Ting, Daniela Weber, Axel Benner, Hannah Hill, Maral Saadati, Jun Yin, Richard M Stone, Guillermo Garcia Manero, Harry P Erba, Geoffrey L Uy, Guido Marcucci, Richard A Larson, Abin Thomas, Sylvie D Freeman, Nuria Marquez Almuina, Konstanze Döhner, Ian Thomas, Nigel H Russel, Hartmut Döhner, Megan K D Othus, Elihu H Estey, Roland Bruno Walter
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts. Leukemia 38 (2) (2024)
Shai Shimony, Jacqueline S Garcia, Julia Keating, Evan C Chen, Marlise R Luskin, Maximilian Stahl, Donna S Neuberg, Daniel J DeAngelo, Richard M Stone, R Coleman Lindsley
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia 38 (7) (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia 38 (9) (2024)
Johann-Christoph Jann, Christopher B Hergott, Marisa Winkler, Yiwen Liu, Benjamin Braun, Anne Charles, Kevin M Copson, Shougat Barua, Manja Meggendorfer, Niroshan Nadarajah, Shai Shimony, Eric S Winer, Martha Wadleigh, Richard M Stone, Daniel J DeAngelo, Jacqueline S Garcia, Torsten Haferlach, R Coleman Lindsley, Marlise R Luskin, Maximilian Stahl, Zuzana Tothova
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes. Leukemia (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland Bruno Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos Enrique Vigil, Robert H Collins, Vinay Jain, Richard M Stone
Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Shai Shimony, Maximilian Stahl, Richard M Stone
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. American journal of hematology 98 (3) (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Vijaya Raj Bhatt, Angela M Ulrich, Geoffrey L Uy, Richard M Stone, Wendy Stock, Michael O Ojelabi, Jun Yin, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Maria R Baer, Selina Chow, Heidi D Klepin, Jennifer G Le-Rademacher, Aminah Jatoi
Outcomes of Older Adults With AML Treated in Community Versus Academic Centers: An Analysis of Alliance Trials. JCO oncology practice (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Shai Shimony, Maximilian Stahl, Richard M Stone
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification and management. American journal of hematology (2023)
Shai Shimony, Maximilian Stahl, Richard M Stone
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. American journal of hematology 98 (3) (2023)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Shai Shimony, Maximilian Stahl, Richard M Stone
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. American journal of hematology 98 (3) (2023)
Shai Shimony, Maximilian Stahl, Richard M Stone
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. American journal of hematology (2023)
Ghayas C Issa, Ibrahim Aldoss, John F Dipersio, Branko Cuglievan, Richard M Stone, Martha Arellano, Michael J Thirman, Manish R Patel, David S Dickens, Shalini Shenoy, Neerav Shukla, Hagop M Kantarjian, Scott A Armstrong, Florian Perner, Jennifer A Perry, Galit Rosen, Rebecca G Bagley, Michael L Meyers, Peter Ordentlich, Yu Gu, Vinit Kumar, Steven Smith, Gerard M McGeehan, Eytan M Stein
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature (2023)
Ali AlJabban, Hyun-Il Paik, Jon C Aster, Nancy Berliner, Jennifer Brouillard, Jennifer R Brown, Kathleen H Burns, Jorge J Castillo, James Card, Paola Dal Cin, Daniel J DeAngelo, David M Dorfman, Benjamin L Ebert, Jacqueline S Garcia, Caron A Jacobson, Hakim Lakhani, Jacob P Laubach, Azra H Ligon, Neal I Lindeman, R Coleman Lindsley, Scott B Lovitch, Marlise R Luskin, Elizabeth A Morgan, Andrew Nowak, Athena Petrides, Geraldine S Pinkus, Olga Pozdnyakova, David P Steensma, Richard M Stone, Olga K Weinberg, Eric S Winer, Annette S Kim
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. JCO oncology practice (2023)
Florian Perner, Eytan M Stein, Daniela V Wenge, Sukrit Singh, Jeonghyeon Kim, Athina Apazidis, Homa Rahnamoun, Disha Anand, Christian Marinaccio, Charlie Hatton, Yanhe Wen, Richard M Stone, David Schaller, Shoron Mowla, Wenbin Xiao, Holly A Gamlen, Aaron James Stonestrom, Sonali Persaud, Elizabeth T Ener, Jevon A Cutler, John G Doench, Gerard M McGeehan, Andrea Volkamer, John D Chodera, Radosław P Nowak, Eric S Fischer, Ross L Levine, Scott A Armstrong, Sheng F Cai
MEN1 mutations mediate clinical resistance to menin inhibition. Nature (2023)
Shai Shimony, Maximilian Stahl, Richard M Stone
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. American journal of hematology 98 (3) (2023)
Courtney D D DiNardo, Stéphane de Botton, Daniel A Pollyea, Richard M Stone, Jessica K Altman, Amir T Fathi, Tharin Limsakun, Min Liang, Sung Choe, Mohammad Hossain, Adriana E Tron, Qian Meng, Stephanie M Kapsalis, Shuchi S Pandya, Eytan M Stein
Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study. American journal of hematology (2023)
Shai Shimony, Maximilian Stahl, Richard M Stone
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. American journal of hematology 98 (3) (2023)
Anna H Yeaton, Geraldine Cayanan, Sanam Loghavi, Igor Dolgalev, Emmett M Leddin, Christian E Loo, Hedieh Torabifard, Deedra Nicolet, Jingjing Wang, Kate Corrigan, Varvara Paraskevopoulou, Daniel T Starczynowski, Eric Wang, Omar Abdel-Wahab, Aaron D Viny, Richard M Stone, John C Byrd, Olga A Guryanova, Rahul M Kohli, Gerardo Andrés Cisneros, Aristotelis Tsirigos, Ann-Kathrin Eisfeld, Iannis Aifantis, Maria Guillamot
The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation. Cancer discovery 12 (10) (2022)
Evan C Chen, Helen Gandler, Isidora Tošić, Geoffrey G Fell, Ashlee Fiore, Olga Pozdnyakova, Daniel J DeAngelo, Ilene Galinsky, Marlise R Luskin, Martha S Wadleigh, Eric S Winer, Rebecca Leonard, Kelsey O'Day, Adrienne de Jonge, Donna S Neuberg, A Thomas Look, Richard M Stone, David A Frank, Jacqueline S Garcia
Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Anjali S Advani, Anna B Moseley, Kristen M O'Dwyer, Brent L Wood, Min Fang, Matthew J Wieduwilt, Ibrahim Aldoss, Jae H Park, Rebecca B Klisovic, Maria R Baer, Wendy Stock, Rupali R Bhave, Megan K D Othus, Richard C Harvey, Cheryl L Willman, Mark R Litzow, Richard M Stone, Elad Sharon, Harry P Erba
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Ellen L Weisberg, Basudev Chowdhury, Chengcheng Meng, Abigail E Case, Wei Ni, Swati Garg, Martin Sattler, Abdel Kareem Azab, Abdel Kareem Azab, Barbara Muz, Dana Sanchez, Anthia Toure, Richard M Stone, Ilene Galinsky, Eric Winer, Scott Gleim, Sofia Gkountela, Alexia Kedves, Edmund Harrington, Tinya Abrams, Thomas Zoller, Andrea Vaupel, Paul Manley, Michael Faller, BoYee Chung, Xin Chen, Philipp Busenhart, Christine Stephan, Keith Calkins, Debora Bonenfant, Claudio R Thoma, William Forrester, James D Griffin
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma. Blood cancer journal 12 (7) (2022)
Andrew Hantel, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Wendy Stock, Sawyer Jacobson, Sumithra J Mandrekar, Richard A Larson, Richard M Stone, Christopher S Lathan, Daniel J DeAngelo, John C Byrd, Gregory A Abel
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (32) (2022)
Yadira M Soto-Feliciano, Francisco J Sánchez Rivera, Florian Perner, Douglas W Barrows, Edward R Kastenhuber, Yu-Jui Ho, Thomas S Carroll, Yijun Xiong, Disha Anand, Alexey A Soshnev, Leah A Gates, Mary Clare Beytagh, David Cheon, Shengqing Stan Gu, X Shirley Liu, Andrei V Krivtsov, Maximiliano Meneses, Elisa De Stanchina, Richard M Stone, Scott A Armstrong, Scott W Lowe, C David Allis
A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition. Cancer discovery (2022)
Nikolaus Jahn, Ekaterina Jahn, Maral Saadati, Lars Bullinger, Richard A Larson, Tiziana Ottone, Sergio Amadori, Thomas W Prior, Joseph M Brandwein, Frederick R Appelbaum, Bruno C Medeiros, Martin S Tallman, Gerhard Ehninger, Michael Heuser, Arnold Ganser, Celine Pallaud, Insa Gathmann, Julia Krzykalla, Axel Benner, Clara D Bloomfield, Christian Thiede, Richard M Stone, Hartmut Döhner, Konstanze Döhner
Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial. Leukemia 36 (9) (2022)
Eric S Winer, Richard M Stone
Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches. Therapeutic advances in hematology 10 (2019)
Richard M Stone, Paul W Manley, Richard A Larson, Renaud Capdeville
Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood advances 2 (4) (2019)
Richard M Stone
3 + 7 + FLT3 inhibitors: 1 + 1 ≠ 2. Blood 129 (9) (2018)
Ofir Wolach, Richard M Stone
How I treat mixed-phenotype acute leukemia. Blood 125 (16) (2015)